QUALIGEN THERAPEUTICS INC (QLGN)
US74754R2022 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 388.15K | 401.80K | N/A | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | 7.03M | 17.54M | 5.95M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.30M | N/A | 540.00K | 820.00K | 0.00 | |||
| Inventories | N/A | N/A | 1.59M | 1.06M | 950.00K | |||
| Other Current Assets | 626.76K | 764.96K | 1.66M | 1.38M | 180.00K | |||
| Total Current Assets | 2.31M | 1.17M | 10.82M | 20.80M | 6.13M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 0.00 | 1.77M | 1.85M | 80.00K | |||
| Goodwill | N/A | N/A | 630.00K | N/A | N/A | |||
| Intangibles | N/A | N/A | 5.85M | 170.00K | 190.00K | |||
| Other Non-Current Assets | N/A | 866.48K | 20.00K | 20.00K | 480.00K | |||
| Total Non-Current Assets | 0.00 | 866.48K | 8.26M | 2.04M | 560.00K | |||
| TOTAL ASSETS | 2.31M | 2.03M | 19.08M | 22.84M | 6.69M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.43M | 1.30M | 950.00K | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 130.00K | |||
| Accrued Expenses | 565.24K | 527.03K | 1.93M | 1.86M | 380.00K | |||
| Accounts Payable | 1.64M | 2.22M | 860.00K | 890.00K | 1.29M | |||
| Other Current Liabilities | 815.93K | 87.58K | 4.87M | 1.89M | 8.83M | |||
| Total Current Liabilities | 4.45M | 4.14M | 8.61M | 4.64M | 1.67M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 360.00K | N/A | N/A | |||
| Other Non-Current Liabilities | N/A | N/A | 1.35M | 1.64M | 400.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 3.24M | 1.63M | 0.00 | |||
| TOTAL LIABILITIES | 4.45M | 4.14M | 11.85M | 6.27M | 1.67M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -122.21M | -116.80M | -103.39M | -84.74M | -82.00M | |||
| Additional Paid In Capital | 120.00M | 114.66M | 110.53M | 101.27M | 86.73M | |||
| Minority Interest | N/A | N/A | 1.53M | N/A | N/A | |||
| Common Shares | 65.31K | 43.26K | 40.00K | 40.00K | 290.00K | |||
| Other Shareholders' Equity | N/A | N/A | 50.00K | N/A | N/A | |||
| Shares Outstanding | 548.28K | 107.24K | 4.21M | 3.53M | 180.00K | |||
| Tangible Book Value per Share | -3.90 | -19.62 | 0.18 | 4.64 | 26.56 | |||
| Total Shareholders' Equity | -2.14M | -2.10M | 7.24M | 16.56M | 5.02M | |||
| TOTAL LIABILITIES AND EQUITY | 2.31M | 2.03M | 19.08M | 22.84M | 6.69M | |||
| Statistics | ||||||||
| Current Ratio | 0.52 | 0.28 | 1.26 | 4.48 | 3.67 | |||
| Return On Assets (ROA) | -343.33% | -659.89% | -97.69% | -78.37% | -292.23% | |||
| Return On Equity (ROE) | N/A | N/A | -257.46% | -108.09% | -389.44% | |||
All data in USD , ROIC based on taxRate of 0.21